Evaluation of Therapeutic Drug Monitoring of Protease Inhibitors on Virologic Success and Tolerance of Highly Active Antiretroviral Therapy (HAART)

NCT00122590 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

115

Enrollment

OTHER_GOV

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: nelfinavir
DRUG: lopinavir/r
DRUG: indinavir
DRUG: ritonavir

Sponsor

French National Agency for Research on AIDS and Viral Hepatitis

Collaborators

[object Object]